Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study
- PMID: 11746612
- DOI: 10.1002/mds.1170
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study
Abstract
We studied the association of Parkinson's disease (PD) with type of menopause (natural or surgical), age at menopause, and postmenopausal estrogen replacement therapy using a case-control design. We used the medical records-linkage system of the Rochester Epidemiology Project to identify 72 women who developed PD in Olmsted County, MN, during the twenty years 1976-1995. Each incident case was matched by age (+/- 1 year) to a general population control subject. We collected exposure data through review of the complete medical records of cases and control subjects in the system. PD cases had undergone hysterectomy (with or without unilateral oophorectomy) significantly more often than control subjects (odds ratio [OR] = 3.36; 95% confidence interval [CI] = 1.05-10.77). In addition, PD cases had experienced early menopause (< or = 46 years) more commonly than control subjects (OR = 2.18; 95% CI = 0.88-5.39). Finally, PD cases had used estrogens orally or parenterally for at least 6 months after menopause less frequently (8%) than control subjects (14%; OR = 0.47; 95% CI = 0.12-1.85). However, the findings for early menopause and estrogen replacement therapy were not statistically significant. Despite the limited sample size of this exploratory study, we hypothesize that there is an increased risk of PD in conditions causing an early reduction in endogenous estrogen. This hypothesis needs to be confirmed in a larger study.
Copyright 2001 Movement Disorder Society.
Similar articles
-
Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.Neurology. 2005 Aug 9;65(3):383-90. doi: 10.1212/01.wnl.0000171344.87802.94. Neurology. 2005. PMID: 16087902
-
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.Neurology. 2009 Oct 27;73(17):1381-7. doi: 10.1212/WNL.0b013e3181bd80c1. Neurology. 2009. PMID: 19858460 Free PMC article.
-
Increased risk of parkinsonism in women who underwent oophorectomy before menopause.Neurology. 2008 Jan 15;70(3):200-9. doi: 10.1212/01.wnl.0000280573.30975.6a. Epub 2007 Aug 29. Neurology. 2008. PMID: 17761549
-
Head trauma preceding PD: a case-control study.Neurology. 2003 May 27;60(10):1610-5. doi: 10.1212/01.wnl.0000068008.78394.2c. Neurology. 2003. PMID: 12771250 Review.
-
Implications for estrogens in Parkinson's disease: an epidemiological approach.Ann N Y Acad Sci. 2006 Nov;1089:373-82. doi: 10.1196/annals.1386.004. Ann N Y Acad Sci. 2006. PMID: 17261781 Review.
Cited by
-
Association of Premenopausal Bilateral Oophorectomy With Parkinsonism and Parkinson Disease.JAMA Netw Open. 2022 Oct 3;5(10):e2238663. doi: 10.1001/jamanetworkopen.2022.38663. JAMA Netw Open. 2022. PMID: 36287560 Free PMC article.
-
Estrogens, Neuroinflammation, and Neurodegeneration.Endocr Rev. 2016 Aug;37(4):372-402. doi: 10.1210/er.2016-1007. Epub 2016 May 19. Endocr Rev. 2016. PMID: 27196727 Free PMC article. Review.
-
The Role of Estrogen in Brain and Cognitive Aging.Neurotherapeutics. 2019 Jul;16(3):649-665. doi: 10.1007/s13311-019-00766-9. Neurotherapeutics. 2019. PMID: 31364065 Free PMC article. Review.
-
Gynecological surgery in adulthood imparts cognitive and brain changes in rats: A focus on hysterectomy at short-, moderate-, and long-term intervals after surgery.Horm Behav. 2023 Sep;155:105411. doi: 10.1016/j.yhbeh.2023.105411. Epub 2023 Aug 31. Horm Behav. 2023. PMID: 37659358 Free PMC article.
-
Prophylactic oophorectomy in premenopausal women and long-term health.Menopause Int. 2008 Sep;14(3):111-6. doi: 10.1258/mi.2008.008016. Menopause Int. 2008. PMID: 18714076 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical